New York State Common Retirement Fund Crinetics Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 148,277 shares of CRNX stock, worth $6.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
148,277
Previous 140,918
5.22%
Holding current value
$6.37 Million
Previous $4.05 Million
52.39%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding CRNX
# of Institutions
240Shares Held
91.2MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.17MShares$394 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.4MShares$275 Million1.78% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$268 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.81MShares$249 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.59MShares$240 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.31B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...